Evidence map›Paper›PMID 37323585›Full record

ArticleFrontiers in cellular neuroscience2023

Investigating cell-specific effects of FMRP deficiency on spiny projection neurons in a mouse model of Fragile X syndrome.

Gabriele Giua, Olivier Lassalle, Leila Makrini-Maleville, Emmanuel Valjent, Pascale Chavis, Olivier J J Manzoni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cell- and Pathway-Specific Disruptions in the Accumbens of Fragile X Mouse.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Gabriele GiuaINMED, INSERM U1249, Marseille, France.
Olivier LassalleINMED, INSERM U1249, Marseille, France.
Leila Makrini-MalevilleIGF, University of Montpellier, INSERM, CNRS, Montpellier, France.
Emmanuel ValjentIGF, University of Montpellier, INSERM, CNRS, Montpellier, France.
Pascale ChavisINMED, INSERM U1249, Marseille, France.
Olivier J J ManzoniINMED, INSERM U1249, Marseille, France.
Aix-Marseille Université · FRAssociated Research (United States) · USCentre National de la Recherche Scientifique · FRInserm · FRInstitut de Neurobiologie de la Méditerranée · FRResearch International (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fragile X syndrome (FXS), resulting from a mutation in the Methods: We utilized a novel Results: Discussion: Our results suggest that the absence of FMRP disrupts the standard dichotomy characterizing NAc D1- and D2-SPNs, resulting in a homogenous phenotype. This shift in cellular properties could potentially underpin select aspects of the pathology observed in FXS. Therefore, understanding the nuanced effects of FMRP absence on SPN subtypes can offer valuable insights into the pathophysiology of FXS, opening avenues for potential therapeutic strategies.

Indexed as

accumbensD1RD2RFragile Xspiny projection neurons

Identifiers

PMID37323585
PMCPMC10264852
OpenAlexW4378908081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.